388 related articles for article (PubMed ID: 7623852)
1. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
Amendt BA; Si ZH; Stoltzfus CM
Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
[TBL] [Abstract][Full Text] [Related]
2. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.
Staffa A; Cochrane A
Mol Cell Biol; 1995 Aug; 15(8):4597-605. PubMed ID: 7623851
[TBL] [Abstract][Full Text] [Related]
3. The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.
Si ZH; Rauch D; Stoltzfus CM
Mol Cell Biol; 1998 Sep; 18(9):5404-13. PubMed ID: 9710624
[TBL] [Abstract][Full Text] [Related]
4. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
Bilodeau PS; Domsic JK; Stoltzfus CM
J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
[TBL] [Abstract][Full Text] [Related]
5. A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.
Wentz MP; Moore BE; Cloyd MW; Berget SM; Donehower LA
J Virol; 1997 Nov; 71(11):8542-51. PubMed ID: 9343212
[TBL] [Abstract][Full Text] [Related]
6. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
Schwartz S; Felber BK; Pavlakis GN
J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
[TBL] [Abstract][Full Text] [Related]
7. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
Amendt BA; Hesslein D; Chang LJ; Stoltzfus CM
Mol Cell Biol; 1994 Jun; 14(6):3960-70. PubMed ID: 8196635
[TBL] [Abstract][Full Text] [Related]
8. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
Damgaard CK; Tange TO; Kjems J
RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
[TBL] [Abstract][Full Text] [Related]
9. A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.
Benko DM; Schwartz S; Pavlakis GN; Felber BK
J Virol; 1990 Jun; 64(6):2505-18. PubMed ID: 2186172
[TBL] [Abstract][Full Text] [Related]
10. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
[TBL] [Abstract][Full Text] [Related]
11. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing.
Caputi M; Mayeda A; Krainer AR; Zahler AM
EMBO J; 1999 Jul; 18(14):4060-7. PubMed ID: 10406810
[TBL] [Abstract][Full Text] [Related]
12. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
13. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
Liao HJ; Baker CC; Princler GL; Derse D
Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
[TBL] [Abstract][Full Text] [Related]
14. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.
Belshan M; Park GS; Bilodeau P; Stoltzfus CM; Carpenter S
Mol Cell Biol; 2000 May; 20(10):3550-7. PubMed ID: 10779344
[TBL] [Abstract][Full Text] [Related]
15. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.
Jacquenet S; Méreau A; Bilodeau PS; Damier L; Stoltzfus CM; Branlant C
J Biol Chem; 2001 Nov; 276(44):40464-75. PubMed ID: 11526107
[TBL] [Abstract][Full Text] [Related]
16. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
17. Inefficient spliceosome assembly and abnormal branch site selection in splicing of an HIV-1 transcript in vitro.
Dyhr-Mikkelsen H; Kjems J
J Biol Chem; 1995 Oct; 270(41):24060-6. PubMed ID: 7592605
[TBL] [Abstract][Full Text] [Related]
18. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
Caputi M; Freund M; Kammler S; Asang C; Schaal H
J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
[TBL] [Abstract][Full Text] [Related]
19. Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.
Cmarko D; Bøe SO; Scassellati C; Szilvay AM; Davanger S; Fu XD; Haukenes G; Kalland KH; Fakan S
J Virol; 2002 Oct; 76(20):10473-84. PubMed ID: 12239324
[TBL] [Abstract][Full Text] [Related]
20. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing.
Schwartz S; Felber BK; Pavlakis GN
Virology; 1991 Aug; 183(2):677-86. PubMed ID: 1830183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
